Current recommendations for monitoring depth of neuromuscular blockade

Current Opinion in Anaesthesiology

Volumn 27, Issue 6, 2014, Pages 616-622

  Lien, Cynthia A ^a   Kopman, Aaron F ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Acceleromyography; Qualitative monitors; Quantitative monitors; Residual neuromuscular block; Train of four ratio

Indexed keywords

CHOLINESTERASE INHIBITOR; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; SUGAMMADEX;

ACCURACY; ANESTHESIA LEVEL; CLINICAL PRACTICE; COST; ELECTRIC PERIPHERAL NERVE STIMULATOR; EXTUBATION; HUMAN; MUSCLE RELAXATION; MUSCLE STRENGTH; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR FUNCTION; NEUROMUSCULAR MONITORING; PATIENT CARE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; ELECTROSTIMULATION; PHYSIOLOGIC MONITORING; POSTOPERATIVE COMPLICATIONS; PROCEDURES;

ELECTRIC STIMULATION; HUMANS; MONITORING, PHYSIOLOGIC; NEUROMUSCULAR BLOCKADE; POSTOPERATIVE COMPLICATIONS;

EID: 84927962322     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0000000000000132     Document Type: Review

References (69)

1. Carter JA, Arnold R, Yate PM, Flynn PJ. Assessment of the Datex Relaxograph during anesthesia and atracurium induced neuromuscular blockade. Br J Anaesth 1986; 58:1447-1452.
2. Jensen E, Viby-Mogensen J, Bang U. The accelograph: a new neuromuscular transmission monitor. Acta Anaesthesiol Scand 1988; 32:49-52.
3. Motamed C, Kirov K, Combes X, Duvaldestin P. Comparison between the Datex-Ohmeda M-NMT module and a force-displacement transducer for monitoring neuromuscular blockade. Eur J Anaesthesiol 2003; 20:467-469.
4. Kopman AF, Yee PS, Neuman GG. Correlation of the train-of-four fade ratio with clinical signs and symptoms of residual curarization in awake volunteers. Anesthesiology 1997; 86:765-771.
5. Eikermann M, Groeben H, Hüsing J, Peters J. Accelerometry of adductor pollicis muscle predicts recovery of respiratory function from neuromuscular blockade. Anesthesiology 2003; 98:1333-1337.
6. Eriksson LI, Sundman E, Olsson R, et al. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyography of awake human volunteers. An-esthesiology 1997; 87:1035-1043.
7. Yip PC, Hannam JA, Cameron AJ, Campbell D. Incidence of residual neu-romuscular blockade in a postanaesthetic care unit. Anaesth Intensive Care 2010; 38:91-95.
8. Esteves S, Martins M, Barros F, et al. Incidence of postoperative residual neuromuscular blockade in the postanaesthesia care unit: an observational multicentre study in Portugal. Eur J Anaesthesiol 2013; 30:243-249.
9. Todd MM, Hindman BJ, King BJ. The implementation of quantitative electro-myographic neuromuscular monitoring in an academic anesthesia depart ment. Anesth Analg 2014; 119:323-331.
10. Fezing AK, d'Hollander A, Boogaerts JG. Assessment of the postoperative residual curarisation using the train of four stimulation with acceleromyogra-phy. Acta Anaesthesiol Belg 1999; 50:83-86.
11. Kim KS, Lew SH, Cho HY, Cheong MA. Residual paralysis induced by either vecuronium or rocuronium after reversal with pyridostigmine. Anesth Analg 2002; 95:1656-1660.
12. Viby-Mogensen J, Jensen NH, Engbaek J, et al. Tactile and visual evaluation of the response to train-of-four nerve stimulation. Anesthesiology 1985; 63:440-443.
13. Thilen SR, Hansen BE, Ramaiah R, et al. Intraoperative neuromuscular monitoring site and residual paralysis. Anesthesiology 2012; 117:964-972.
14. Beemer GH, Rozental P. Postoperative neuromuscular function. Anaesth Intensive Care 1986; 14:41-45.
15. Heier T, Caldwell JE, Feiner JR, et al. Relationship between normalized adductor pollicis train-of-four ratio and manifestations of residual neuro-muscular block: a study using acceleromyography during near steady-state concentrations of mivacurium. Anesthesiology 2010; 113:825-832.
16. Murphy GS, Szokol JW, Marymount JH, et al. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 2008; 107:130-137.
17. Kumar GV, Nair AP, Murthy HS, et al. Residual neuromuscular blockade affects postoperative pulmonary function. Anesthesiology 2012; 117:1234-1244.
18. Sauer M, Stahn A, Soltesz S, et al. The influence of residual neuromuscular block on the incidence of critical respiratory events. A randomised, prospective, placebo-controlled trial. Eur J Anaesthesiol 2011; 28:842-848.
19. Hårdemark Cedborg AI, Sundman E, Bodén K, et al. Pharyngeal function and breathing pattern during partial neuromuscular block in the elderly: effects on airway protection. Anesthesiology 2014; 120:312-325.
20. Murphy GS, Szokol JW, Avram MJ, et al. Postoperative residual neuromus-cular blockade is associated with impaired clinical recovery. Anesth Analg 2013; 117:133-141.
21. Phillips S, Stewart PA, Bilgin AB. A survey of the management of neuromus-cular blockade monitoring in Australia and New Zealand. Anaesth Intensive Care 2013; 41:374-379.
22. Kotake Y, Ochiai R, Suzuki T, et al. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Anesth Analg 2013; 117:345-351.
23. Kirkegaard H, Heier T, Caldwell JE. Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block. Anesthesiology 2002; 96:45-50.
24. Fuchs-Buder T, Meistelman C, Alla F, et al. Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose effect relationship for neostigmine. Anesthesiology 2009; 112:34-40.
25. Helbo-Hansen HS, Bang U, Nielson HK, Skovgaard LT. The accuracy of train of four monitoring at various stimulation currents. Anesthesiology 1992; 76:199-203.
26. Brull SJ, Ehrenwerth J, Silverman DG. Stimulation with submaximal current for train-of-four monitoring. Anesthesiology 1990; 72:629-632.
27. Mylrea KC, Hameroff SR, Calkins JM, et al. Evaluation of peripheral nerve stimulators and relationship to possible errors in assessing neuromuscular blockade. Anesthesiology 1984; 60:464-466.
28. Mortimer JT. Motor prosthesis. In: Brooks VB, editor. American handbook of physiology, Supplement 2. Hoboken, New Jersey: Wiley-Blackwell; 1981. pp. 155-187.
29. Pierce PA, Mylrea KC, Watt RC, et al. Effects of pulse duration on neuro-muscular blockade monitoring: implications for supramaximal stimulation. J Clin Monit 1986; 2:169-173.
30. Viby-Mogensen J. Postoperative residual curarization and evidence-based anaesthesia. Br J Anaesth 2000; 84:301-303.
31. Eriksson LI. Evidence-based practice and neuromuscular monitoring: it's time for routine quantitative assessment. Anesthesiology 2003; 98:1037-1039.
32. El-Orbany M, Ali HH, Baraka A, Salem MR. Residual neuromuscular block should, and can, be a 'never event'. Anesth Analg 2014; 118:691.
33. Naguib M, Kopman AF, Lien CA, et al. A survey of current neuromuscular practice in the United States and Europe. Anesth Analg 2010; 111:110-119.
34. Davis DA, Taylor-Vaisey A. Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. CMAJ 1997; 157:408-416.
35. Baillard C, Clec'h C, Catineau J, et al. Postoperative residual neuromuscular block: a survey of management. Br J Anaesth 2005; 95:622-626.
36. Hemmerling TM, Donati F. The M-NMT mechanosensor cannot be considered as a reliable clinical neuromuscular monitor in daily anesthesia practice. Anesth Analg 2002; 95:1826-2182.
37. Motamed C, Bourgain JL, D'Hollander A. Survey of muscle relaxant effects management with a kinemyographic-based data archiving system: a retrospective quantitative and contextual quality control approach. J Clin Monit Comput 2013; 27:669-676.
38. Stewart PA, Freelander N, Liang S, et al. Comparison of electromyography and kinemyography during recovery from nondepolarizing neuromuscular blockade. Anaesth Intensive Care 2014; 42:378-384.
39. Liang SS, Stewart PA, Phillips S. An ipsilateral comparison of acceleromyo-graphy and electromyography during recovery from nondepolarizing neuro-muscular block under general anesthesia in humans. Anesth Analg 2013; 117:373-379.
40. Donati F, Meistelman C, Plaud B. Vecuronium neuromuscular blockade at the adductor muscles of the larynx an adductor pollicis. Anesthesiology 1991; 74.:833-837.
41. Hemmerling TM, Schmidt J, Hanusa C, et al. Simultaneous determination of neuromuscular block at the larynx, diaphragm, adductor pollicis, orbicularis oculi and corrugator supercilii muscles. Br J Anaesth 2000; 85:856-860.
42. Baillard C, Gehan G, Reboul-Marty J, et al. Residual curarization in the recovery room after vecuronium. Br J Anaesth 2000; 84:394-395.
43. de Jong RH. Controlled relaxation. I. Clinical management of muscle-relaxant administration. JAMA 1966; 197:113-115.
44. de Jong RH. Controlled relaxation. II Clinical management of muscle-relaxant administration. JAMA 1966; 198:1163-1166.
45. Tammisto T, Olkkola KT. Dependence of the adequacyofmuscle relaxation on the degree of neuromuscular block and depth of enflurane anesthesia during abdominal surgery. Anesth Analg 1995; 80:543-547.
46. King M, Sujirattanawimol N, Danielson DR, et al. Requirements for muscle relaxants during radical retro-pubic prostatectomy. Anesthesiology 2000; 93:1392-1397.
47. Chen B, Tan L, Zhang L, Shang Y. Is muscle relaxant necessary in patients undergoing laparoscopic gynecological surgery with a ProSeal LMATM?J Clin Anesth 2013; 25:32-35.
48. Li Y, Liu Y, Xu C, et al. The effects of neuromuscular blockade on operating conditions during general anesthesia for spinal surgery. J Neurosurg Anesthe-siol 2014; 26:45-49.
49. Beemer GH, Bjorksten AR, Dawson PJ, et al. Determinantsofthe reversal time of competitive neuromuscular block by anticholinesterases. Br J Anaesth 1991; 66:469-475.
50. Mencke T, Echternach M, Kleinschmidt S, et al. Laryngeal morbidity and quality of tracheal intubation: a randomized controlled trial. Anesthesiology 2003; 98:1049-1056.
51. Geldner G, Niskanen M, Laurila P, et al. A randomized controlled trial comparing sugammadex and neostigmine at different depths of neuromus-cular blockade in patients undergoing laparoscopic surgery. Anaesthesia 2012; 67:991-998.
52. Dubois PE, Mulier JP. A review of the interest of sugammadex for deep neuromuscular blockade management in Belgium. Acta Anaesthesiol Belg 2013; 64:49-60.
53. von Quillfeldt S, Föhre B, Andrees N, et al. Rocuronium reversed by sugam-madex versus mivacurium during high-risk eye surgery: an institutional anaesthetic practice evaluation. J Int Med Res 2013; 41:1740-1751.
54. Werba A, Klezl M, Schramm X, et al. The level of neuromuscular block needed to suppress diaphragmatic movement during tracheal suction in patients with raised intracranial pressure: a study with vecuronium and atracurium. Anaesthesia 1993; 48:301-303.
55. Fernando PUE, Viby-Mogensen J, Bonsu AK, et al. Relationship between posttetanic count and response to carinal stimulation during vecuronium-induced neuromuscular blockade. Acta Anaesthiol Scand 1987; 31:593-596.
56. Yasir M, Mehta KS, Banday VH, et al. Evaluation of post operative shoulder tip pain in low pressure versus standard pressure pneumoperitoneum during laparoscopic cholecystectomy. Surgeon 2012; 10:71-74.
57. Brull SJ, Murphy GS. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness. Anesth Analg 2010; 111:129-140.
58. Kopman AF, Zank LM, Ng J, Neuman GG. Antagonism of cisatracurium and rocuronium block at a tactile train-of-four count of 2: should quantitative assessment of neuromuscular function be mandatory? Anesth Analg 2004; 98:102-106.
59. Pietraszewski P, Gasynski T. Residual neuromuscular block in elderly patients after surgical procedures under general anaesthesia with rocuronium. Anaes-thesiol Intensive Ther 2013; 45:77-81.
60. Fuchs-Buder T, Meistelman C, Alla F, et al. Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationships for neostigmine. Anesthesiology 2010; 112:34-40.
61. Donati F. Residual paralysis: a real problem or did we invent a new disease? Can J Anaesth 2013; 60:714-729.
62. Kopman AF, Sinha N. Acceleromyography as a guide to anesthetic manage ment: a case report. J Clin Anesth 2003; 15:145-148.
63. Pongrácz A, Szatmári S, Nemes R, et al. Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation. Anesthesiology 2013; 119:36-42.
64. Caldwell JE. Reversal of residual neuromuscular block with neostigmine at one to four hours after a single intubating dose of vecuronium. Anesth Analg 1995; 80:1168-1174.
65. Greer R, Harper NJN, Pearson AJ. Neuromuscular monitoring by intensive care nurses: comparison of acceleromyography and tactile assessment. Br J Anaesth 1998; 80:384-385.
66. Bevan JC, Collins L, Fowler C, et al. Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children. Anesth Analg 1999; 89:333-339.
67. Murphy GS, Szokol JW, Marymount JH, et al. Intraoperative acceleromyo-graphy monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit. Anesthesiology 2008; 109:389-398.
68. Caldwell JE. Reversal of residual neuromuscular block with neostigmine at one to four hours after a single intubating dose of vecuronium. Anesth Analg 1995; 80:1168-1174.
69. Naguib M, Kopman AF, Ensor JE. Neuromuscular monitoring and postoperative residual curarization. Br J Anaesth 2007; 99:297-299.